Company
Shenzhen New Industries Biomedical Engineering Co. Ltd
Headquarters: Shenzhen, China
Employees: 1,949
Market Cap
CN¥54.12 Billion
CNY as of Jan. 1, 2025
US$7.41 Billion
Shenzhen New Industries Biomedical Engineering Co. Ltd Categories
China Healthcare Medical DevicesChina Healthcare China Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Shenzhen New Industries Biomedical Engineering Co., Ltd., a bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals and laboratories in China and internationally. It offers immunology, clinical chemistry, and integrated systems, as well as immunoassay and clinical chemistry reagent kits. The company was founded in 1995 and is based in Shenzhen, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥4.44 B |
| EBITDA | CN¥2.13 B |
| Gross Profit TTM | CN¥2.87 B |
| Profit Margin | 41.72% |
| Operating Margin | 42.57% |
| Quarterly Revenue Growth | 15.40% |
Stocks & Indices
Shenzhen New Industries Biomedical Engineering Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300832 wb_incandescent